Cost Utility of Geriatric Assessment and Management in Older Adults With Cancer: From Evidence to Implementation
Menée dans un contexte canadien, cette étude analyse le rapport coût-efficacité d'une prise en charge gériatrique de patients âgés atteints d'un cancer
As the population of older adults with cancer grows,1 the oncology community faces the challenge of delivering evidence-based, person-centered, and sustainable care. Geriatric assessment and management (GAM) has long been advocated as a strategy to optimize outcomes by tailoring cancer treatment to the vulnerabilities of diverse aging patient populations. Although the clinical benefits of GAM have been reported widely, central to informing health policy and implementation at scale is the cost-effectiveness of GAM
Journal of Clinical Oncology , éditorial, 2025